Literature DB >> 12757900

Modulation of the human glucocorticoid receptor function by antidepressive compounds.

Miho Okuyama-Tamura1, Masahiko Mikuni, Itaru Kojima.   

Abstract

Hyperactivity of the hypothalamic-pituitary-adrenal axis is associated with depression. We investigated the effect of various types of antidepressant agents in vitro on the function of glucocorticoid receptor (GR). Desipramine, clomiplamine, fluoxetine, milnacipran and clorgyline all induced rapid and sustained translocation of GR into the nucleus of human lymphocytes. In contrast, major and minor tranquilizers, lithium and verapamil, a blocker of membrane steroid transporter, were without effect. These antidepressants did not affect GR-mediated transcription by themselves, but significantly inhibited dexamethasone-induced transcription. These results indicate that structurally different antidepressants induce translocation of GR and inhibit GR-mediated transcription.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12757900     DOI: 10.1016/s0304-3940(03)00261-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Identification of molecules potentially involved in mediating the in vivo actions of the corticotropin-releasing hormone receptor 1 antagonist, NBI30775 (R121919).

Authors:  Anke Post; Frauke Ohl; Osborne F X Almeida; Elisabeth B Binder; Monika Rücker; Sandra Welt; Elke Binder; Florian Holsboer; Inge Sillaber
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

2.  The Effects of Venlafaxine and Dexamethasone on the Expression of HSP70 in Rat C6 Glioma Cells.

Authors:  Jaehak Yu; Sungwon Roh; Jun-Seok Lee; Byung-Hwan Yang; Mi Ran Choi; Young Gyu Chai; Seok Hyeon Kim
Journal:  Psychiatry Investig       Date:  2010-02-08       Impact factor: 2.505

3.  Long-term imipramine treatment affects rat brain and pituitary corticosteroid receptors and heat shock proteins levels in a gender-specific manner.

Authors:  I Elaković; J Brkljacić; G Matić
Journal:  J Neural Transm (Vienna)       Date:  2007-03-29       Impact factor: 3.575

4.  Antidepressants, but not antipsychotics, modulate GR function in human whole blood: an insight into molecular mechanisms.

Authors:  L A Carvalho; B A Garner; T Dew; H Fazakerley; C M Pariante
Journal:  Eur Neuropsychopharmacol       Date:  2010-03-15       Impact factor: 4.600

5.  Japanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in Japan.

Authors:  Teruhiko Higuchi; Mike Briley
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

6.  Effect of selective serotonin reuptake inhibitors and immunomodulator on cytokines levels: an alternative therapy for patients with major depressive disorder.

Authors:  María Eugenia Hernandez; Danelia Mendieta; Mayra Pérez-Tapia; Rafael Bojalil; Iris Estrada-Garcia; Sergio Estrada-Parra; Lenin Pavón
Journal:  Clin Dev Immunol       Date:  2013-11-17

7.  Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance.

Authors:  Matteo Martino; Giulio Rocchi; Andrea Escelsior; Michele Fornaro
Journal:  Curr Neuropharmacol       Date:  2012-06       Impact factor: 7.363

8.  The effect of imipramine, ketamine, and zinc in the mouse model of depression.

Authors:  Andrzej Wróbel; Anna Serefko; Piotr Wlaź; Ewa Poleszak
Journal:  Metab Brain Dis       Date:  2015-07-10       Impact factor: 3.584

9.  Comparison of the neurobiological effects of attribution retraining group therapy with those of selective serotonin reuptake inhibitors.

Authors:  C Wang; N Zhang; Y L Zhang; J Zhang; H Yang; T C Timothy
Journal:  Braz J Med Biol Res       Date:  2013-03-19       Impact factor: 2.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.